| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_322aca15a8ff839b4a25f40c47fd7cf1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9259cfa966fe620251340a003f5d6125 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-223
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-545 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-22 |
| filingDate |
2004-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_910a0fe090bf92bcc4429bcfa66723cd |
| publicationDate |
2004-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004100996-A1 |
| titleOfInvention |
Vitronectin receptor antagonist compounds and their use in the preparation of radiopharmaceuticals |
| abstract |
The present invention is directed to a compound comprising a thiol derivatized targeting moiety. The targeting moiety binds to a receptor which his upregulated during angiogenesis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7919581-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9326316-B2 |
| priorityDate |
2003-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |